Fosun Pharma

Pharma

Novartis-Argo, Eisai, Henlius—Fierce Pharma Asia

Novartis signed a $5.2 billion siRNA deal with Argo. The FDA approved subcutaneous Leqembi. The Hong Kong exchange censured Henlius and its former CEO.

Angus Liu Sep 5, 2025 9:00am

Ivonescimab, Fosun-Sitala, Hutchmed—Fierce Pharma Asia

Aug 29, 2025 8:15am

Padcev-Keytruda result, Alzheimer's med, Fosun—Fierce Pharma Asia

Aug 15, 2025 8:31am

Takeda, AZ-Daiichi, Fosun-Henlius—Fierce Pharma Asia

Jan 24, 2025 8:55am

Henlius Biotech shareholders reject proposed takeover by Fosun

Jan 22, 2025 12:09pm

Daiichi, Fosun, Yuhan and more—Fierce Pharma Asia

Sep 27, 2024 10:15am